Reuters Health News Summary

Cereulide, which can cause nausea and vomiting, has been detected ⁠in ingredients from a factory in China supplying ⁠a large ‌number of baby formula makers including Nestle, Danone and Lactalis, triggering recalls in ⁠dozens of countries and raising concerns ‍among parents.

Following is a summary of current health news briefs.

Eli Lilly ‌to build $3.5 billion Pennsylvania plant in US manufacturing push

Eli Lilly announced on ⁠Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an ​effort to expand U.S. production and bolster medical ‍supply chains. The $3.5 billion plant will make Lilly's injectable weight-loss medications, including retatrutide, the company said in a statement. That next-generation ⁠obesity ‌drug has ⁠outperformed Lilly's blockbuster drug Zepbound.

France tightens infant milk rules after ‍recalls

France has lowered the safety limit for ​cereulide toxin in infant formula, aiming to strengthen protections ⁠after several major groups ordered worldwide recalls over contamination concerns, ⁠the farm ministry said on Saturday. Cereulide, which can cause nausea and vomiting, has been detected ⁠in ingredients from a factory in China supplying ⁠a large ‌number of baby formula makers including Nestle, Danone and Lactalis, triggering recalls in ⁠dozens of countries and raising concerns ‍among parents.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)